Farmers & Merchants Investments Inc’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$493K Hold
12,625
0.01% 251
2026
Q1
$411K Buy
12,625
+750
+6% +$24.1K 0.01% 249
2025
Q4
$418K Sell
11,875
-750
-6% -$26.6K 0.01% 251
2025
Q3
$332K Hold
12,625
0.01% 265
2025
Q2
$335K Hold
12,625
0.01% 262
2025
Q1
$305K Sell
12,625
-1,025
-8% -$32.4K 0.01% 271
2024
Q4
$549K Hold
13,650
0.02% 234
2024
Q3
$864K Buy
13,650
+400
+3% +$23.5K 0.03% 204
2024
Q2
$702K Buy
+13,250
New +$869K 0.02% 216

Other funds holding VKTX

Farmers & Merchants Investments Inc's VKTX Position: Q2 2026 in Review

Farmers & Merchants Investments Inc held its Viking Therapeutics (VKTX) position steady in Q2 2026 at 12,625 shares worth $493K. The position accounts for 0.01% of the portfolio, ranked #251.

Farmers & Merchants Investments Inc first reported a position in VKTX in Q2 2024 and has held it in 9 quarters since. The position peaked at $864K in Q3 2024. 236 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Farmers & Merchants Investments Inc held 12,625 shares of Viking Therapeutics worth $493K as of Q2 2026.
  • Farmers & Merchants Investments Inc left its Viking Therapeutics share count unchanged in Q2 2026.
  • Viking Therapeutics made up 0.01% of Farmers & Merchants Investments Inc's portfolio in Q2 2026, its #251 holding.
  • Farmers & Merchants Investments Inc first reported a position in Viking Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Farmers & Merchants Investments Inc's Viking Therapeutics position peaked at $864K in Q3 2024.
  • 236 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Farmers & Merchants Investments Inc's 13F filing for Q2 2026, filed 20 Jul 2026.